TARTARASE
Commercial- Indications
- Dental tartar
Company intelligence / Profile preview
Pontis Biologics has developed a proprietary enzyme-based dentifrice, Tartarase™, designed to dissolve dental calculus. In a proof-of-principle randomized human clinical trial, the product demonstrated safety and efficacy in reducing existing dental tartar compared to standard toothpaste. The study showed that the Tartarase™ formulation could decrease calculus formation without adverse effects over four weeks.[4][5] The company is preparing for further human trials with recognized partners in dentistry.[2]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pontis Biologics, Inc..